Diagnostics for membranous nephropathy

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/564 (2006.01) G01N 33/68 (2006.01)

Patent

CA 2731065

The invention relates to immunoassays, reagents, therapeutics and methods of diagnosing and prognosis evaluation of idiopathic membranous nephropathy (MN). Immunoassays comprise enzyme-linked immunoabsorbent assays and nephelometric immunoassays for serum auto-antibodies reactive against a phospholipase A2 receptor (PLA2R). Therapeutic methods include removal of the auto-antibodies by adsorbance or administration of soluble PLA2R or fragments to sequester the auto-antibodies.

L'invention concerne des immuno-essais, des réactifs, des agents thérapeutiques et des procédés de diagnostic et de pronostic d'évaluation d'une néphropathie membraneuse idiopathique (MN). Des immuno-essais comportent des analyses dimmuno-adsorbants liés à une enzyme, et des immuno-essais néphélométriques pour des auto-anticorps de sérum réactifs à un récepteur de phospholipase A2 (PLA2R). Des procédés thérapeutiques comprennent l'élimination des auto-anticorps par procédé adsorbant ou par ladministration de PLA2R soluble ou de fragments pour séquestrer les auto-anticorps.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Diagnostics for membranous nephropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diagnostics for membranous nephropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostics for membranous nephropathy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1752062

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.